Skip to content
Targeting Phage Therapy Congress
  • Home
  • Scientific Committee
  • Agenda
  • Tracks
  • Abstract Submission
  • Registration
  • Venue
  • Conference Replay
  • Abstracts Book
  • Press Releases
  • Previous Conferences
  • Contact

Phage Therapy 2020 Congress

Posted on July 6, 2017December 6, 2019 by Targeting Phage Therapy
Share with:
Facebook
fb-share-icon
X (Twitter)
Tweet
LinkedIn
Share
Wechat
Posted in slide
Post navigation
Pr Brian Jones will present his study on “Control of catheter associated biofilms through efflux inhibition”
Development of Infection-responsive surface coatings for bacteriophage delivery in the catheterised urinary tract: strategic presentation of Targeting Phage & Antibiotic Resistance Conference

Targeting Phage Therapy News

  • Practical Session: How to Produce, Manufacture, and Bring Phage Products to Market
  • Keynote Speech 2025: Prof. Robert T. Schooley
  • Berlin will Host Targeting Phage Therapy 2025 on June 10-11
  • Targeting Phage Therapy 2024 Replay
  • Phage Therapy 2024 Concluding Remarks by Jean-Paul Pirnay: Towards Personalized Phage Therapy

Read more...

Scientific News

  • Clinical Application of Bacteriophage Therapy in Children
  • Bacteriophage Therapy: A New Approach for Severe Bacterial Infections
  • KlebPhaCol: Revealing the Gut’s Hidden Phage Potential in Klebsiella Research
  • The Hidden Architects of the Gut: Phage-Bacteria Dynamics in Early Childhood Development
  • Personalized Bacteriophage Therapy: Insights from 100 Consecutive Cases
  • Exploring the Phageome: Differences in Healthy and Atopic Dermatitis SkinExploring the Phageome: Differences in Healthy and Atopic Dermatitis Skin
  • Untapped Potential: Phage Model Systems as Next-Generation Therapeutic Agents
  • Armed phages are heading for clinical trialsArmed phages are heading for clinical trials
  • Vibrio cholerae CBASS System Revolutionizes Antibiotic SensitivityVibrio cholerae CBASS System Revolutionizes Antibiotic Sensitivity
  • Nearly complete structure of bacteriophage DT57C has been revealed

Read more...

Newsletters & Press Release

Press Release

Newsletter Archives

  • Sign up for Newsletter

Media Partner

Follow Us

  • Linkedin
  • Facebook

  • News & Media

    Clinical Application of Bacteriophage Therapy in Children

    Bacteriophage Therapy: A New Approach for Severe Bacterial Infections

    KlebPhaCol: Revealing the Gut’s Hidden Phage Potential in Klebsiella Research

    The Hidden Architects of the Gut: Phage-Bacteria Dynamics in Early Childhood Development

    Personalized Bacteriophage Therapy: Insights from 100 Consecutive Cases

    Exploring the Phageome: Differences in Healthy and Atopic Dermatitis Skin

    Exploring the Phageome: Differences in Healthy and Atopic Dermatitis Skin

    Untapped Potential: Phage Model Systems as Next-Generation Therapeutic Agents

    Armed phages are heading for clinical trials

    Armed phages are heading for clinical trials

    Vibrio cholerae CBASS System Revolutionizes Antibiotic Sensitivity

    Vibrio cholerae CBASS System Revolutionizes Antibiotic Sensitivity

    Nearly complete structure of bacteriophage DT57C has been revealed

    View more
Theme: Vogue by Kaira
  • Scientific Committee
  • Abstract Submission
  • Tracks
  • Registration
  • Venue
  • Scientific News
  • Newsletters
  • Press Releases
  • Contact
Copyright © 2025 - Targeting Phage Therapy
General Sales Conditions | Privacy Policy